secwatch.observer — SEC 8-K summary
======================================

Issuer:     TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
CIK:        0000818686
Form:       8-K
Filed at:   2025-06-05T23:59:59+00:00
Accession:  0001193125-25-135942
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Teva shareholders elect board, approve executive compensation and auditor at annual meeting
--------------------------------------------------------------------------------

- Chen Lichtenstein elected to board until 2027; Amir Elstein, Roberto Mignone, Perry Nisen, Tal Zaks elected until 2028.
- Non-binding advisory vote on executive compensation approved with 688.8M for vs 99.2M against.
- Amended compensation policy for executives and directors approved with 710.2M for.
- Reappointment of Kesselman & Kesselman (PwC) as auditor approved with 820.2M for.
- All proposals passed with substantial majorities; no material dissent reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818686/000119312525135942/0001193125-25-135942-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818686/000119312525135942/d90930d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-135942

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer